• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三分之一日需求的早餐蛋白质摄入量可维持远端胃切除术后的瘦体质量。

Breakfast Protein Intake of One-third of Daily Requirement Can Maintain Lean Body Mass Post-distal Gastrectomy.

机构信息

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.

Department of Nutrition, Kanagawa Cancer Center, Yokohama, Japan.

出版信息

In Vivo. 2024 Nov-Dec;38(6):2897-2903. doi: 10.21873/invivo.13771.

DOI:10.21873/invivo.13771
PMID:39477381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535947/
Abstract

BACKGROUND/AIM: Post-gastrectomy lean body mass (LBM) decrease has a significant negative impact on postoperative survival in patients with cancer. This study investigated the effect of intake of at least one-third of the daily protein requirement at breakfast on the maintenance of LBM in patients during the first month post-gastrectomy.

PATIENTS AND METHODS

Among patients with gastric cancer who underwent curative distal gastrectomy between April 2011 and December 2018, without adjuvant chemotherapy, we evaluated 401 patients who had consumed more than the daily protein requirement in the first month postoperatively, using the FFQW82 nutrition intake questionnaire. Patients were divided into those who consumed more (≥1/3 intake group, n=160) and those who consumed less than one-third of the daily protein requirement at breakfast (<1/3 intake group, n=241). We compared the LBM reduction rate at one month postoperatively between groups. Univariate and multivariate analyses were performed to determine clinicopathological factors predicting LBM reduction at one month postoperatively.

RESULTS

The LBM reduction rate at one month post-curative distal gastrectomy was significantly higher in the <1/3 intake group than in the ≥1.3 intake group (p=0.01) at breakfast. Multivariate analysis showed that morning protein intake below one-third of the daily requirement independently predicted LBM reduction (odds ratio=1.75, 95% confidence interval=1.14-2.68, p<0.01).

CONCLUSION

Consuming at least one-third of the daily protein requirement at breakfast may be effective in maintaining LBM in patients undergoing curative distal gastrectomy. These results may be very important for prognosis, since maintaining LBM influences the continuation of adjuvant chemotherapy and thus survival after curative resection in patients with gastric cancer.

摘要

背景/目的:胃癌患者胃切除术后瘦体重(LBM)减少对术后生存有显著的负面影响。本研究旨在探讨在胃切除术后第一个月内,早餐摄入至少三分之一日常蛋白质需求对维持患者 LBM 的影响。

方法

在 2011 年 4 月至 2018 年 12 月期间接受根治性远端胃切除术且未接受辅助化疗的胃癌患者中,我们使用 FFQW82 营养摄入问卷评估了 401 例术后第一个月内摄入超过日常蛋白质需求的患者。将患者分为早餐摄入超过三分之一(≥1/3 摄入组,n=160)和低于三分之一日常蛋白质需求的患者(<1/3 摄入组,n=241)。比较两组术后一个月 LBM 减少率。进行单因素和多因素分析,以确定预测术后一个月 LBM 减少的临床病理因素。

结果

根治性远端胃切除术后一个月,<1/3 摄入组的 LBM 减少率明显高于≥1.3 摄入组(p=0.01)。多因素分析显示,早餐时蛋白质摄入量低于日常需求的三分之一独立预测 LBM 减少(优势比=1.75,95%置信区间=1.14-2.68,p<0.01)。

结论

在胃切除术后患者中,早餐摄入至少三分之一的日常蛋白质需求可能有助于维持 LBM。这些结果对于预后非常重要,因为维持 LBM 会影响辅助化疗的持续时间,从而影响胃癌根治性切除术后的生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b3c/11535947/264cd7ac8f7d/in_vivo-38-2899-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b3c/11535947/264cd7ac8f7d/in_vivo-38-2899-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b3c/11535947/264cd7ac8f7d/in_vivo-38-2899-g0001.jpg

相似文献

1
Breakfast Protein Intake of One-third of Daily Requirement Can Maintain Lean Body Mass Post-distal Gastrectomy.三分之一日需求的早餐蛋白质摄入量可维持远端胃切除术后的瘦体质量。
In Vivo. 2024 Nov-Dec;38(6):2897-2903. doi: 10.21873/invivo.13771.
2
Effect of Preoperative Gastric Shape on Loss of Lean Body Mass After Distal Gastrectomy.术前胃形状对远端胃切除术后去脂体重丢失的影响。
In Vivo. 2024 Jan-Feb;38(1):445-452. doi: 10.21873/invivo.13458.
3
Changes in lipid indices and body composition one year after laparoscopic gastrectomy: a prospective study.腹腔镜胃手术后一年脂质指数和身体成分的变化:一项前瞻性研究。
Lipids Health Dis. 2018 May 11;17(1):113. doi: 10.1186/s12944-018-0729-1.
4
Early administration of postoperative BCAA-enriched PPN may improve lean body mass loss in gastric cancer patients undergoing gastrectomy.术后早期给予富含支链氨基酸的 PPN 可能会改善胃癌患者胃切除术后的去脂体重丢失。
Langenbecks Arch Surg. 2023 Aug 25;408(1):336. doi: 10.1007/s00423-023-03045-6.
5
The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.胃中部癌的最佳胃切除范围:在不牺牲长期生存率的情况下,远端次全胃切除术在短期效果上优于全胃切除术。
BMC Cancer. 2017 May 19;17(1):345. doi: 10.1186/s12885-017-3343-0.
6
[Comparison of postoperative mid-term and long-term quality of life between Billroth-I gastroduodenostomy and Billroth-II gastrojejunostomy after radical distal gastrectomy in patients with gastric cancer: a cohort study based on a case registry database].胃癌患者根治性远端胃切除术后毕Ⅰ式胃十二指肠吻合术与毕Ⅱ式胃空肠吻合术术后中期和长期生活质量的比较:一项基于病例登记数据库的队列研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 May 25;25(5):401-411. doi: 10.3760/cma.j.cn441530-20220304-00081.
7
Does a laparoscopic approach attenuate the body weight loss and lean body mass loss observed in open distal gastrectomy for gastric cancer? a single-institution exploratory analysis of the JCOG 0912 phase III trial.腹腔镜手术是否能减轻开腹远端胃癌根治术引起的体重减轻和去脂体重丢失?日本癌症研究集团 0912 期临床试验的单机构探索性分析。
Gastric Cancer. 2018 Mar;21(2):345-352. doi: 10.1007/s10120-017-0735-4. Epub 2017 Jun 16.
8
Dietary Intake After Surgery in Patients With Gastric Cancer Who Underwent Laparoscopic-assisted Those Who Underwent Conventional Gastrectomy.腹腔镜辅助与传统胃癌根治术后患者的膳食摄入比较。
Anticancer Res. 2024 Jan;44(1):409-415. doi: 10.21873/anticanres.16826.
9
Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer.胃癌胃切除术后瘦体重丢失的危险因素
Ann Surg Oncol. 2016 Jun;23(6):1963-70. doi: 10.1245/s10434-015-5080-4. Epub 2016 Jan 13.
10
Lean body mass change over 6 years is associated with dietary leucine intake in an older Danish population.在丹麦老年人群中,6年期间的去脂体重变化与膳食亮氨酸摄入量有关。
Br J Nutr. 2016 May;115(9):1556-62. doi: 10.1017/S0007114516000611. Epub 2016 Mar 16.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Supplementation of Protein at Breakfast Rather Than at Dinner and Lunch Is Effective on Skeletal Muscle Mass in Older Adults.早餐而非晚餐和午餐补充蛋白质对老年人骨骼肌质量有效。
Front Nutr. 2021 Dec 21;8:797004. doi: 10.3389/fnut.2021.797004. eCollection 2021.
3
Distribution of dietary protein intake in daily meals influences skeletal muscle hypertrophy via the muscle clock.
膳食蛋白质在每日餐次中的分配通过肌肉时钟影响骨骼肌肥大。
Cell Rep. 2021 Jul 6;36(1):109336. doi: 10.1016/j.celrep.2021.109336.
4
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial.一项比较辅助性单药 S1、S-1 联合奥沙利铂与术后 S-1 和奥沙利铂放化疗在接受 D2 根治术后淋巴结阳性胃癌患者中的随机 III 期临床试验:ARTIST2 试验。
Ann Oncol. 2021 Mar;32(3):368-374. doi: 10.1016/j.annonc.2020.11.017. Epub 2020 Dec 3.
5
Japanese gastric cancer treatment guidelines 2018 (5th edition).《日本胃癌治疗指南2018(第5版)》
Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.
6
Cancer and the Circadian Clock.癌症与生物钟。
Cancer Res. 2019 Aug 1;79(15):3806-3814. doi: 10.1158/0008-5472.CAN-19-0566. Epub 2019 Jul 12.
7
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.多西他赛联合口服氟嘧啶可提高 III 期胃癌患者的疗效:JACCRO GC-07 随机对照试验的中期分析。
J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.
8
Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial.四项疗程与八项疗程辅助 S-1 治疗 II 期胃癌患者(JCOG1104 [OPAS-1]):一项开放标签、III 期、非劣效性、随机试验。
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):208-216. doi: 10.1016/S2468-1253(18)30383-2. Epub 2019 Jan 22.
9
Loss of skeletal muscle mass after curative gastrectomy is a poor prognostic factor.根治性胃切除术后骨骼肌质量的丧失是一个不良预后因素。
Oncol Lett. 2018 Jul;16(1):1341-1347. doi: 10.3892/ol.2018.8747. Epub 2018 May 18.
10
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?辅助化疗 S-1 起始时间或持续时间;哪项真正影响 II 期和 III 期胃癌的生存?
Gastric Cancer. 2018 May;21(3):446-452. doi: 10.1007/s10120-017-0767-9. Epub 2017 Sep 30.